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Abstract
Caveolae and lipid rafts are two distinct populations of free cholesterol, sphingolipid (FC/SPH)-rich cell surface microdomains. They
differ in stability, shape, and the presence or absence of caveolin (present in caveolae) or GPI-anchored proteins (enriched in lipid rafts). In
primary cells, caveolae and rafts support the assembly of different signaling complexes, though signal transduction from both is strongly
dependent on the presence of FC. It was initially thought that FC promoted the formation of inactive reservoirs of signaling proteins. Recent
data supports the concept of a more dynamic role for FC in caveolae and probably, also lipid rafts. It is more likely that the FC content of
these domains is actively modulated as protein complexes are formed and, following signal transduction, disassembled. In transformed cell
lines with few caveolae, little caveolin and a preponderance of rafts, complexes normally assembled on caveolae may function in rafts, albeit
with altered kinetics. However, caveolae and lipid rafts appear not to be interconvertible. The presence of non-caveolar pools of caveolin in
recycling endosomes (RE), the trans-Golgi network (TGN) and in mobile chaperone complexes is now recognized. A role in the uptake of
microorganisms by cells ascribed to caveolae now seems more likely to be mediated by cell surface rafts.
D 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cells receive information from their extracellular space
in the form of signals transmitted via cell surface receptors.
While most signals are protein-dependent, their transduction
is strongly influenced by the local composition of lipids
within the plasma membrane. These, mainly phospholipids
(PL) and free cholesterol (FC), are present in a heteroge-
neous array of microdomains of different compositions. In
artificial membranes made from lipid mixtures with a
composition similar to that of cells, domains rich in FC
and sphingolipids (SPH), resembling those associated with
signaling intermediates in native membranes, separate as a
liquid-ordered phase. In turn, these FC/SPH-rich micro-
domains are influenced by the presence of proteins.
Originally considered to form a single, detergent-insolu-
ble glycolipid-enriched (DIG) membrane fraction, two
major kinds of FC/SPH-containing microdomains are now
recognized to coexist within the plasma membrane. In this
review, lipid rafts are defined as planar domains enriched in
glycosylphosphatidylinositol (GPI)-anchored proteins and
deficient in caveolin. Caveolae are cell surface invaginations
stabilized by structural proteins (caveolins) and deficient in
GPI-anchored proteins. Though occasional planar cell sur-
face domains containing caveolin, as well as caveolin-free
flask-shaped invaginations have been reported, these appear
to be rare structures concerning whose composition and
further existence nothing is known. Several general reviews
of lipid rafts and caveolae have recently appeared [1–4].
The present account focuses on the divergent roles of these
microdomains in biology, and the interaction between their
lipid and protein moieties in regulating signal transduction.
2. Structure and composition of rafts and caveolae
Recent studies, using fluorescence resonance techniques,
suggest that rafts have a mean diameter between f 25 and
several hundred microns [5,6]. It was suggested earlier that
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rafts moved within the exofacial leaflet of the membrane
bilayer [7]. It now seems more likely that rafts also involve
the cytofacial leaflet via organized (though not necessarily
identical) lipids imposed by the association of rafts with
transmembrane signaling proteins such as rho-A, fyn and the
interleukin receptor IL2R-beta [8–10]. Rafts are also
enriched in GPI-anchored proteins [11,12] (Table 1). As
these do not traverse the membrane bilayer, they probably
have little effect on the organization of the inner membrane
leaflet. Rafts contain unusual amounts of ethanolamine
plasmalogens and phosphatidylserine [13]. Ganglioside
GM3 was concentrated in a raft fraction prepared from
detergent-extracted cells [11].
Caveolae are cell surface invaginations, the diameter of
whose opening at the cell surface is typically 60–80 nm.
Caveolae contain more FC (relative to SPH) than rafts
[11,13]. Ganglioside GM3 was reported to be undetectable
in caveolae [11]. Caveolae were enriched in intact ganglio-
side GM1 in A431 cells as evidenced by their selective
binding of cholera toxin B-subunit [14] but in cells in which
caveolae are decreased or absent, GM1 was recovered in
lipid rafts [15,16].
Caveolae contain the structural protein caveolin-1,
present in caveolae in the form of high molecular weight
oligomers. A second caveolin (caveolin-2) is usually also
present. GPI-anchored proteins are largely or completely
absent from caveolin-containing microdomains [11,12].
Caveolae co-purify with receptor kinases including the
platelet-derived growth factor receptor (PDGF-R), the insu-
lin receptor protein (IR), and with related linkers and
signaling intermediates such as shc and h-ras. Protein kinase
A, adenyl cyclase, and several isoforms of protein kinase C
are recovered in purified caveolae fractions [17]. Each of
these proteins can bind directly to caveolin via a ‘scaffold’
site containing the sequences fxxxxfxxf or fxxfxxxxf,
where f is F, Y or W, and x is any amino acid. Caveola-
associated proteins (such as scavenger receptor BI, SR-BI)
involved in lipid homeostasis lack a formal caveolin-bind-
ing domain [18]. The association of these proteins with
caveolae probably involves their lipid, rather than their
protein moiety. It seems likely that this class of proteins
would normally distribute freely between lipid rafts and
caveolae, though experimental evidence for this is presently
limited.
Caveolae are detectable to some extent at the surface of
most cells though their density varies many-fold in different
lines. Primary lymphocytes and blood monocytes were
thought earlier to be devoid of caveolins; more sensitive
techniques have identified low levels of these proteins in
these cells [19,20]. Caveolin was not detected under base-
line conditions in several cancer or transformed cell lines
[21] but even here, caveolae in large numbers can be
expressed under appropriate conditions, for example follow-
ing the induction of drug resistance in MCF-7 human
cancer-derived cells [22], or the transformation of mono-
cyte-derived cell lines with phorbol esters [23]. In summary,
probably all nucleated mammalian cells retain an inherent
ability to form both caveolae and lipid rafts.
3. Stability of rafts and caveolae
Rafts are mobile within the cell surface, to an extent
proportional to their FC content [5]. The association
between FC and SPH is spontaneous in films made from
sphingolipid and phospholipid mixtures [24], but may be
modified by interactions with GPI-anchored and signaling
proteins. Conversely, complex formation between signaling
proteins at the cell surface may facilitate separation of the
liquid-ordered phase [25]. Single-particle tracking of gold-
linked thy-1 (a GPI-anchored protein) indicated its retention
for 7–9 s within raft domains 260–330 nm in diameter [6].
A somewhat longer lifespan (1 min) was reported earlier
using different techniques [5]. All recent studies are con-
sistent in suggesting that lipid rafts have a relatively short
lifespan.
In contrast to the ephemeral nature of caveolin-free
lipid rafts [1,5,6], a recent investigation indicated that
caveolae were stable and possibly semi-permanent mem-
brane structures in epithelial cells. Their turnover under
normal conditions was negligible compared to that of
other differentiated surface domains, such as clathrin-
coated pits [26]. The expression of caveolae is reduced
in the presence of cyclodextrin, which depletes cell FC
nonspecifically [27,28]. Hyperphosphorylation of caveolin
(induced by the protein phosphatase inhibitor okadaic
acid) [29] and dissociation of microtubules with nocoda-
zole [30] also reduced the numbers of cell surface
caveolae. Though the level of caveolae at the cell surface
is responsive to metabolic inhibitors, this finding need not
imply that caveolae recycle spontaneously between cell
surface and intracellular pools under physiological con-
ditions, and there is little evidence to date that they do.
In some cell lines—for example, Fisher rat thyroid (FRT)
cells—overexpression of caveolin is associated with an
increase in the numbers of cell surface invaginations [31].
Morphologically, these appear to be similar or identical to
normal caveolae, though a quantitative comparison of their
effectiveness in signal transduction and lipid homeostasis
has not been undertaken. In other cells—for example,
human prostate carcinoma (NcaP) cells—overexpression
of caveolin leads to the formation, not of surface pits, but
of caveolin bound to intracellular lipid vesicles [31]. A
similar result was obtained in cells transfected with a
dominant-negative mutant caveolin [32]. The presence of
several additional kinds of intracellular complexes contain-
ing caveolin has been described. Caveolin co-purifies with
markers of the trans-Golgi network (TGN) in fibroblasts as
part of a recycling pathway for internalized preformed
lipoprotein FC [33]. Caveolin was also associated with
transferrin receptors in recycling endosomes (RE), mildly
acidified vesicles which bypass the lysosomal pathway to
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return undegraded proteins to the cell surface [34]. Chaper-
one complexes of caveolin, heat shock proteins, and cyclo-
phyllins transferring FC to caveolae from intracellular lipid
pools have also been described [35]. These data emphasize
that caveolin is present in multiple pools in the cell (Fig. 1)
and that the presence of caveolin within a vesicle need not
imply its origin from caveolae, or the expression of func-
tional caveolae at the cell surface.
Despite lipid compositional similarities between caveolae
and lipid rafts, there is little evidence that the two major
classes of FC/SPH-rich microdomains are interconvertible.
Fusion of chaperone complexes or transport vesicles with
preexisting caveolae is probably responsible for replacing
lipid (mainly FC) lost via efflux from the cell, or by leakage
to other membrane domains. Present evidence strongly
suggests that caveolae and lipid rafts are distinct structures,
which normally play different roles in cell biology. Never-
theless, there is recent evidence that rafts and caveolae can
partially substitute for each others’ signaling functions,
although with modified kinetics, if one class is experimen-
tally deleted. When caveolin is completely absent from
cells, signaling complexes which are usually associated with
caveolae may bind, though less effectively, to cell surface rafts [31]. The IR protein whose primary sequence includes
a caveolin-binding scaffold sequence, and which is located
in caveolae in normal adipocytes, partitioned into lipid rafts
in caveola-free liver-derived cells [36]. Endothelial nitric
oxide synthase (eNOS), much of which normally functions
within caveolae, associated with lipid rafts in the absence of
caveolae [31]. In CHO cells, where both species of FC/SPH-
rich domain coexist, crosstalk between lipid rafts and
caveolae was identified by depleting them of either GPI-
anchored proteins or caveolin [12]. In the former case,
caveolin and the expression of caveolae increased and
overexpression of caveolin decreased the synthesis of
GPI-anchored proteins. When caveolin was absent, the
synthesis of GPI-anchored proteins, and their incorporation
into rafts, was stimulated (Fig. 2).
4. Functions of rafts and caveolae
Caveolae function in the transduction of cell surface
signals, and in the regulation of cholesterol homeostasis.
These activities now appear to be closely interrelated
[17,18]. The former depends on the capacity of caveolin
to organize the complexes of receptor kinases, adapters and
small GTP-binding proteins which initiate signal transduc-
tion from the cell surface. The latter depends on access to
extracellular FC acceptors, particularly high-density lipo-
protein (HDL). Interrelationship between the lipid- and
protein-dependent activities of caveolae is suggested by
the following observations. The effectiveness of signal
transduction from caveolae is sensitive to their FC content
[18]. The rate of cholesterol transfer into and out of caveolae
responds to the phosphorylation of signaling proteins during
signal transduction [37].
Fig. 1. The identity and possible relationships of intracellular and plasma
membrane caveolin pools. The continuous arrows show intracellular FC
transfers. The lysosomal pathway (dashed arrow) is highly downregulated
in the presence of normal (lipoprotein-containing) media. The numbered
sites (1–3) represent membrane compartments where caveolin has been
detected (in addition to caveolae, 4) and from which FC–caveolin
complexes may be transported. TGN (Ref. [33]); RE (Ref. [34]); ER
(Ref. [35]). Also shown in the figure are coated pits (CP). Transferrin
receptors (TfR), which are recycled non-caveolar cell surface domains from
recycling endosomes.
Fig. 2. Crosstalk between caveolae and lipid rafts. Reciprocal changes in
the numbers of caveolae and GPI-anchored proteins following the selective
deletion of one or other structure are illustrated. Cells deficient in GPI-
anchored protein production were obtained following selection for
aerolysin-resistance; cells overexpressing caveolin were selected following
transfection with caveolin-1 cDNA [12]. Loss of caveolae was accom-
panied by upregulation of the expression of GPI-anchored proteins within
rafts, while deletion of GPI-anchored proteins was associated with an
upregulation of caveolae.
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The composition of signaling complexes associated with
rafts differs from those in caveolae. In part this relates to the
enrichment in caveolae of proteins with a caveolin-binding
domain, and the absence of these proteins from caveolin-
free lipid rafts [17]. It also reflects the use of leukocytes,
which lack caveolae, for isolation of rafts. In contrast,
signaling proteins in caveolae have usually been character-
ized from caveola-rich cells such as endothelial and smooth
muscle cells, adipocytes and fibroblasts.
FC-depletion, induced by the presence of cyclodextrin,
led to the dissociation of signaling proteins from lipid rafts
[38] and from caveolae [39]. Probably as a result of their
brief lifetime, no data has yet been obtained to show if lipid
rafts can serve as selective donors for FC efflux to HDL in
the manner described for caveolae [18].
Both caveolae and lipid rafts have also been implicated
in the uptake of viruses and bacteria into cells. Such a
pathway would permit the microorganism to bypass lyso-
somal degradation. Echovirus, HIV, SV40, polyoma and
Ebola and Marburg viruses are among those reported to be
internalized via FC/SPH-rich microdomains [40–44] (Fig.
3). Chlamydia, Brucella and E. coli are among the bacteria
reported to be taken up via these pathways [45–47], though
these microorganisms are much larger in size than caveolae.
It has been suggested that such targeting might involve the
co-opting of a signal transduction pathway as a means of
inducing uptake by the host cell, but the identity of the
mechanism involved has not been identified in most cases.
The experimental criteria used in different studies to
establish caveola- or raft-dependent uptake of microorgan-
isms include an association of bacterial endocytic vesicles
with caveolin during infection; colocalization of microor-
ganisms with GPI-anchored proteins; and inhibition of
infection by reactions that sequester cholesterol, such as
filipin and cyclodextrins. Several of these criteria apply to
both caveolae and rafts. Also, caveolin is a component of
several intracellular vesicle populations in addition to cav-
eolae [33,34]. As a result, it has been difficult to definitively
determine if a given microorganism makes its primary
entrance into the host cell via a caveola or a lipid raft.
The situation is made more complicated by the observation
that the same organism may infect simultaneously via
several different endocytic pathways [47]. In cases where
a dependence of infection on GPI-anchored proteins was
established [48], the data shown in Table 1 suggest that rafts
are more likely to have been involved. This conclusion was
recently strengthened by the demonstration that activated
integrins, which are localized to rafts [49] facilitate the
attachment and uptake of Echo and Hanta viruses by
mammalian cells [50]. However, further research is still
needed to fully characterize the molecular association of
bacteria and viruses with FC/SPH-rich domains.
Lipid rafts (though not caveolae) have also been impli-
cated in viral shedding from the cell surface [51,52]. Many
of the same microorganisms which enter cells via caveolae
or lipid rafts are enveloped by a host-derived FC/SPH-rich
membrane when shed from mammalian cells. Conceivably,
the mature bacterium or virus may be targeted for budding
to preexisting rafts in the plasma membrane of the host cell.
Alternatively, FC and SPH might be recruited from intra-
cellular pools such as the TGN. Finally, targeting of the
microorganism to the cell surface could induce raft forma-
tion by recruitment of FC and SPH from other membrane
microdomains. These alternatives have yet to be distin-
guished.
Before caveolae and lipid rafts could be distinguished
experimentally, the former had also been broadly implicated
in protein transport to and from the cell surface [53–55].
Since ganglioside GM-1, used as a marker for caveolae, can
Fig. 3. Internalization, maturation and shedding of HIV virus—relationship
to lipid rafts. Infection involves recognition of lipid rafts by viral Nef
protein [95]. Following replication and assembly within the TGN and
cytoplasm, newly synthesized virus appear to be targeted by the same
protein to preexisting or newly assembled rafts for shedding. Specific
interaction between Nef and host GPI-anchored protein Lck has been
identified [96].
Table 1
Properties of lipid rafts and caveolae
Lipid rafts Caveolae
Major lipids FC, SPH FC, SPH
Structure planar invaginated
Major proteins GPI-anchored
proteins
caveolins
Major signal
binding motif
acylation caveolin-binding
‘scaffold’ sequencea
Half-life short (min) long (hours)
FC-dependent yes yes
FC dynamically
regulated
? yes
a While acylation appears to be fundamentally more important in
binding signaling proteins to rafts than to caveolae [94], eNOS is both
caveolin-targeted and functionally acylated [87] while EGF-R, with a
caveolin-binding sequence, can distribute between lipid rafts and caveolae
[16,91].
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distribute between both classes of microdomains, the role
for GPI-anchored proteins in apical targeting suggests the
major role is played by lipid rafts.
5. Caveolae in endothelial cells
While caveolae in endothelial cells possess many of the
same properties as those in other cells, in some respects,
they appear unusual. The number of caveolae at the endo-
thelial surface is high, relative to that in most other cells.
Comparison of the properties of normal and caveola-defi-
cient endothelial cells suggests that endothelial caveolae, in
contrast to other cell lines, can generate endocytic vesicles
at a rate which allows them to contribute significantly to the
transcytosis of albumin and potentially, other plasma pro-
teins [56]. This may reflect the same properties that promote
GTP-dependent ‘budding’ of caveolin-rich vesicles via the
activity of dynamin in isolated endothelial cell membranes
[57]. The GTPase inhibitor GTPgS was without effect on
membranes from fibroblasts (unpublished data). Electron
microscopic and biochemical data of endothelial caveolae
indicated that the caveolar ‘bowl’ in endothelial cells was
contiguous with a ‘rim’ of GPI-anchored proteins [58,59].
In contrast, data concerning caveolae and rafts in other cell
types has suggested a lack of functional association between
microdomains containing caveolin and those containing
GPI-anchored proteins (Table 1). If endothelial caveolae
are more labile that those in most other cells (and a direct
kinetic study has not yet been carried out) the molecular
basis for this difference might lie in the degree of oligome-
rization of caveolin; the presence or absence of specific
dynamins; or possibly the presence or organization of
ancillary proteins.
6. Cholesterol trafficking in lipid rafts and caveolae
At least in caveola-rich primary cells such as fibroblasts
and smooth muscle cells, these microdomains are the
preferential cell surface endpoint for the trafficking of both
newly synthesized FC, and the preformed FC which
recycles from plasma lipoproteins, mainly low-density lip-
oprotein (LDL) through the cell [60,61]. At equilibrium FC
efflux (typically 1.0–1.5 102 nmol min 1 Ag 1 cell FC
for fibroblastic cells) is the sum of synthesis de novo (1–2
nmol min 1 Ag 1 cell FC) and the influx of preformed FC
[62]. Thus, the greatest part of FC which exits from
caveolae is derived from the selective uptake and recycling
of preformed FC from other plasma lipoproteins, particu-
larly LDL. This pathway may involve FC, caveolin-rich
recycling endosomes [33,34].
Peripheral cells in vivo are surrounded by interstitial
fluid rich in lipoprotein acceptors of FC, particularly HDL
[63]. In the presence of plasma lipoproteins, caveolar FC
was rapidly transferred out of the cell, with a t1/2 of < 5 min
[59]. In the absence of an external, FC-binding acceptor, FC
was lost from caveolae to non-caveolar membrane domains,
by a slower pathway (t1/2 20 min) [61] (Fig. 4).
In cells such as fibroblasts and vascular smooth muscle
cells, the expression of caveolin levels rapidly responds to
changes in cellular FC content. When FC is increased,
caveolin transcription is stimulated by a SREBP-1-depend-
ent mechanism, the number of cell surface caveolae
increased, and FC efflux is stimulated [64]. The opposite
reaction took place when cell sterol was reduced by loss of
FC [65]. In endothelial cells, where the expression of
caveolin and caveolae is high under baseline conditions,
FC uptake is accompanied not by additional expression of
caveolae, but by incorporation of additional FC into preex-
isting caveolae [66].
There is an almost complete dearth of experimental data
on whether FC levels in lipid rafts can be regulated
independently of the composition of the bulk phase of
membrane lipids. Additionally, it is not known if FC can
be transferred directly to preformed rafts via intracellular
transport complexes; and if so, whether these are the same
complexes that supply FC to caveolae. The transient exis-
tence of rafts makes it more likely that their FC content
reflects mainly the local lipid composition of the membrane.
7. Signal transduction from lipid rafts and caveolae
Before caveolae and rafts could be experimentally dis-
tinguished, the detergent-insoluble fraction of cell mem-
branes was known to be enriched in proteins implicated in
the early steps of transmembrane signaling [67]. Depletion
of FC from the plasma membrane was carried out with
cyclodextrin, a FC-binding oligosaccharide which (though
not specific for FC/SPH-rich domains) [68], removed mem-
brane FC, releasing signaling proteins from caveolae and
Fig. 4. Spatial and temporal vectors in the transfer of FC from caveolae.
The figure compared the kinetics of the movement of FC from caveolae by
lateral diffusion or efflux. Transfer of FC through the plane of the plasma
membrane to adjacent microdomains, the only pathway available in the
absence of an extracellular FC receptor, probably reflects simple diffusion
[60]. Loss of FC from caveolae to the extracellular space in the presence of
lipid-poor (prebeta-migrating) HDL [61] probably reflects a facilitated
transport pathway involving the binding of HDL to the cell surface [97].
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activating several signal transduction pathways [38,69–73].
In contrast, when plasma levels of FC were increased by
preincubation of endothelial cells with FC, association of
eNOS with caveolae was increased, and signaling activity or
enzyme activity decreased [74]. IR and h-ras binding to
caveolae were also increased by FC, and decreased by FC
depletion [75]. However, the effects of FC depletion in this
case were dependent on IR kinase substrate [76]. Together,
these data suggest that the effects of FC on caveola-
mediated signaling are more complex than originally
thought, and involve both positive and negative effects at
different points during the signaling reaction.
In lymphocytes and in some transformed cells, lipid rafts
are present at high densities while appreciable numbers of
caveolae are absent. The rafts are enriched in signaling
proteins. Awell studied example is the association in T cells
of immunoglobulin receptors with the dually acylated src
family kinase lyn [77]. Mutation of its palmitoylation site
reduces the association of lyn with rafts, and increases the
phosphorylation of upstream and downstream intermediates,
and intracellular Ca+ + levels [78]. Mutation of both palmi-
toyl and myristoyl sites rendered lyn incapable of membrane
binding and thus inactive in membrane transduction. Signal-
ing via the T cell receptor complex and in particular, the role
of Lck in initiating signal transduction, was strongly depend-
ent upon the integrity of lipid rafts [79]. Lipid depletion
dissociates the complex and inhibits signal transduction.
Similarly, IL-2 signaling in human lymphoma cells media-
ting the phosphorylation of STAT proteins was dependent
upon association of the IL-2 and IL-6 receptors with lipid
rafts at the cell surface [15,80]. Finally, fas-mediated apop-
tosis of lymphocytes, and the co-proteins FADD and cas-
pase-8, depend on fas incorporation into FC/SPH-rich lipid
rafts [81]. Disruption of rafts following FC depletion was
associated with the inhibition of apoptosis.
One possible explanation of the marked heterogeneity of
response which characterizes the relationship between FC
and signal transduction from the cell surface would be that
protein complexes differ in the affinity of their ‘functional’
and ‘storage’ pools for FC/SPH-rich domains. According to
this hypothesis, signal transduction would be stimulated by
FC in pathways whose reactive intermediates were selec-
tively bound to caveolae and/or rafts; but the process would
be inhibited by FC in pathways activated by FC depletion,
for example by cyclodextrin. There are several difficulties
with this. First, it could hardly explain how investigators
using different assays could obtain opposite results for the
effect of FC on the same pathway. For example, h-ras
binding to caveolin is induced by FC-activated ras-depend-
ent signaling in endothelial cells. In contrast, a stimulation
of ras-dependent signaling was reported in FC-depleted
Rat-1 fibroblasts [65,72]. A convincing case for membrane
microdomains as promoters of the assembly of protein
complexes by mass action effects based on the high local
concentrations induced was also recently made [82]. It is
hard to envisage conditions in which the dilution of aggre-
gates from microdomains promoted their association. In
fact, calculations based on the size of rafts and caveolae
suggest concentrations of signaling intermediates could be
locally increased 103-fold over those in cytoplasm. These
considerations suggest that both the ‘stimulatory’ and
‘inhibitory’ roles of rafts and caveolae could represent
dynamic phases of the same reaction cycle, in which signal-
ing proteins, first assembled in FC-rich caveolae or rafts,
were phosphorylated then expelled from these microdo-
mains as the result of a coordinated loss of FC (Fig. 5). If
this were the case, whether the effect of FC was positive or
negative would depend on the reaction step assayed. Gus-
tavsson et al. [75] demonstrated that FC stimulated the
association of h-ras with caveolae. Furuchi et al. [39]
measured the stimulation by FC depletion of PDGF-medi-
ated ras activity by assaying the subsequent phosphoryla-
tion of ERK. Kranenburg et al. [71] reported that FC
negatively regulated the response to epidermal growth factor
(EGF).
The broad conclusion that caveolin-binding proteins sig-
nal from caveolae, while others signal from rafts, is compli-
Fig. 5. Steps in PDGF-mediated signal transduction and the role of
caveolae. The figure illustrates dimerization and ligand binding of PDGF-R,
followed by its autophosphorylation, and signal transduction to signaling
intermediate proteins. Following its subsequent exclusion from the caveola,
the PDGF/PDGF-R complex is internalized via coated pits, and degraded
lysosomally [86]. The exit of FC during signal transduction, and its
recovery from internal pools, is also illustrated.
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cated by the recent observation that the EGF receptor protein
(EGF-R), which includes a caveolin-binding ‘scaffold’
sequence, can also signal from rafts. In caveola-poor HeLa
cells, EGF-R under basal conditions is localized mainly to
non-caveolar lipid rafts [16]. Cholesterol-depletion in these
cells stimulates EGF binding, by increasing the availability of
EGF-R. Cholesterol loading decreases EGF-mediated signal
transduction. In contrast, in caveola-rich vascular smooth
muscle cells, EGF-R was recovered following immunopre-
cipitation with caveolin antibody [71]. Angiotensin II
induced the transactivation of EGF-R by promoting the
insertion of angiotensin receptors into caveolae and activa-
tion of the protein kinase B signaling pathway. After phos-
phorylation of EGF-R, the receptor protein dissociated from
caveolae. Activation of signaling by EGF under these con-
ditions was inhibited following cyclodextrin-mediated deple-
tion of FC. These data indicate that even the presence of a
caveolin-binding domain is not always sufficient to target a
signaling protein exclusively to caveolae.
8. Dynamic aspects of FC trafficking and signal
transduction
The examples described above indicate that changes in
membrane FC levels had significant but variable effects on
signaling from caveolae and lipid rafts. Until recently, it was
unclear if these were mainly pharmacological effects, or if
systematic changes in FC levels in these domains were an
integral part of effective signal transduction. PDGF-medi-
ated signaling was among those first demonstrated to
originate from caveolae [73,83,84]. Following ligand bind-
ing, PDGF-R is phosphorylated and signal transduction
initiated, while PDGF-R moves out of FC-rich caveolae
[85] for internalization and degradation via the lysosomal
pathway [86]. However, the direct role, if any, of caveolar
FC content in these changes was unclear.
Some insight into this question was recently obtained by
simultaneously measuring FC homeostasis and PDGF-
dependent protein kinase activities in the caveolae of
vascular smooth muscle cells [37]. Within 5 min of the
addition of PDGF, there was a substantial reduction of
caveolar FC content associated with a transient compensa-
tory 3–4-fold increase in FC efflux to the extracellular lipid
acceptor apo A-1, the major protein of HDL. Under these
conditions, caveolar FC decreased by 60–80% (Fig. 6).
This decrease was confirmed using a labeled photoactivable
analog of FC, followed by analysis of caveolin-bound
radioactivity. In the absence of apo A-1, PDGF was without
effect on FC efflux. Caveolar FC was reduced, but signifi-
cantly less. In the presence of apo A-1 (and accelerated
reduction of caveolar FC) protein kinase activity was
increased 2–3-fold.
These data suggest an intimate relationship between FC
homeostasis and signal transduction. PDGF-mediated phos-
phorylation stimulated FC efflux, which in turn amplified
signal transduction, and accelerated the dissociation of the
signal complex from the caveola. This reaction was not
accompanied by any decrease in cell surface caveolin,
suggesting that equilibrium was rapidly restored. Since
PDGF-R is not recycled to a significant extent [86] and
caveolae are stable [26], it seems likely that the lipid-
depleted caveolae are recharged with FC and PGF-R from
other cell surface microdomains or intracellular pools.
It is not yet clear if ligand binding to and phosphorylation
of other receptor kinases is accompanied by similar induced
changes in caveolar FC. eNOS localization to caveolae is
dynamically modified by acylation [87], to regulate the
activation of the muscarinic cholinergic receptor [88]. The
association of eNOS with caveolae is highly FC-sensitive
[89,90]. If the activation of eNOS is linked to transient
changes in caveolar FC, this could represent an additional
example of a self-regulatory cycle within caveolae involving
FC. In Swiss 3T3 cells EGF-R, in non-caveolar rafts prior to
addition of EGF, was translocated to caveolae in the
presence of ligand in a reaction dependent upon caveolin-
1 and inhibited by cyclodextrin, before being displaced as
signal transduction progressed [73]. If cyclodextrin is acting
Fig. 6. PDGF/caveola interactions. Regulation of caveolar FC content
during signal transduction: caveolar FC unloading stimulated by PDGF-
dependent protein kinase activity. Panel A, caveolin-associated FC in 3H-
FC labeled vascular smooth muscle cells in the presence or absence of the
HDL protein apo A-1 (10 Ag ml 1) and PDGF (100 ng ml 1) . Panel B, the
same protocol from cells equilibrated with the photoactivable FC analog,
FCBP. The data illustrates the major decrease in caveolar FC content which
is mediated by PDGF and PDGF-R (from Ref. [37]).
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here mainly to reduce caveolar FC, this data suggests that
the reaction sequence for EGF may be similar to that
described for PDGF [37]. In A431 and Hep-2 carcinoma
cell lines, EGF-R was absent from both rafts and caveolae in
baseline cells, but transferred to rafts (not caveolae) in the
presence of EGF [91]. These data contrast with the caveolar
location of EGF receptors in vascular smooth muscle cells
[16]. One factor determining the distribution of a given
receptor kinase between caveolae and lipid rafts may be the
relative levels of each in different cells, with primary cells
being generally higher, and transformed cells generally
lower, in the expression of caveolae.
9. Comparison of the functions of rafts and caveolae
We suggest that caveolae represent a differentiated,
evolved species of FC/SPH-rich domains. These structures
are stabilized by caveolin, optimized for signaling via
receptor kinases by caveolin ‘scaffold’ binding, and speci-
alized for FC efflux to the small, prebeta fraction of HDL.
The development of an invaginated structure may impede
the access of larger lipoprotein particles. In combination,
these effects magnify signal transduction from the surface of
caveola-rich cells. Caveolae, downregulated during mitosis
[92] are more developed in a number of highly differentiated
cells. Rafts are the major FC/SPH-rich domain of trans-
formed cells and circulating leukocytes.
10. Further research
More information is needed in several areas covered by
this review. If loss of caveolar FC is linked to caveolin
phosphorylation, the kinase involved remains unidentified.
The stability of caveolae [26] suggests that caveolin phos-
phorylation is reversible. At least one phosphatase coloc-
alizes with caveolae [93], but its specificity has not been
determined. Finally, the relationship between FC binding
and phosphorylation in caveolin remains undefined. Con-
tinued research will thus be required to further establish the
molecular basis of the dynamic relationship between signal-
ing and FC outlined in this review.
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